De novo RYR1 heterozygous mutation (I4898T) causing lethal core-rod myopathy in twins. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue European Journal of Medical Genetics Année : 2011

De novo RYR1 heterozygous mutation (I4898T) causing lethal core-rod myopathy in twins.

Résumé

"Core-rod myopathy" is a rare congenital myopathy characterized by the presence of "cores" and "rods" in distinct locations in the same or different muscle fibres. This association is linked currently to mutations in RYR1, NEB and ACTA1 genes. We report identical twins who presented with polyhydramnios and loss of fetal motility during pregnancy; hypotonia, arthrogryposis and swallowing impairment at birth; need of immediate respiratory support and death at 27 and 50 days of life. Muscle biopsies, performed at 27 days of life in twin 1 and at 49 days in twin 2, showed the presence of separate cores and rods in the muscle fibres, both at light and electron microscopy. The molecular analysis showed a heterozygous de novo mutation (Ile4898Thr) of the RYR1 gene. The molecular study of ACTA1, TMP2 and TMP3 genes did not show abnormalities. This is the first report of a lethal form of congenital "core-rod myopathy". The mutation Ile4898Thr has been previously described in central core disease but not in core-rod myopathy. The report enlarges the phenotypic spectrum of "core-rod myopathy" and highlights the morphological variability associated to special RYR1 mutations.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-00639653 , version 1 (09-11-2011)

Identifiants

Citer

Aurelio Hernandez-Lain, Isabelle Husson, Nicole Monnier, Caroline Farnoux, Guy Brochier, et al.. De novo RYR1 heterozygous mutation (I4898T) causing lethal core-rod myopathy in twins.. European Journal of Medical Genetics, 2011, 54 (1), pp.29-33. ⟨10.1016/j.ejmg.2010.09.009⟩. ⟨inserm-00639653⟩
186 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More